Cover Image
市場調查報告書

Rodos BioTarget GmbH的產品平台分析

Rodos BioTarget GmbH - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 320923
出版日期 內容資訊 英文 18 Pages
訂單完成後即時交付
價格
Back to Top
Rodos BioTarget GmbH的產品平台分析 Rodos BioTarget GmbH - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 18 Pages
簡介

Rodos BioTarget GmbH是總公司設立於德國的生物製藥企業,正在開發藥物遞輸的平台。TargoSphere是實現可遞送表現抗原的細胞為標的之有效成分的技術平台,適用於C型肝炎病毒和HIV病毒、結核菌、退伍軍人菌、抗藥性金黃色葡萄球菌的感染疾病的治療上。

本報告提供Rodos BioTarget GmbH的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Rodos BioTarget GmbH的基本資料

  • Rodos BioTarget GmbH概要
  • 主要資訊
  • 企業資料

Rodos BioTarget GmbH:R&D概要

  • 主要的治療範圍

Rodos BioTarget GmbH:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Rodos BioTarget GmbH:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Rodos BioTarget GmbH:藥物簡介

  • RBT-05
  • RBT-06
  • RBT-07
  • RBT-08

Rodos BioTarget GmbH:開發平台分析

  • 各分子類型

Rodos BioTarget GmbH:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06898CDB

Summary

Global Markets Direct's, 'Rodos BioTarget GmbH - Product Pipeline Review - 2015', provides an overview of the Rodos BioTarget GmbH's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Rodos BioTarget GmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Rodos BioTarget GmbH including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Rodos BioTarget GmbH's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Rodos BioTarget GmbH's pipeline products

Reasons to buy

  • Evaluate Rodos BioTarget GmbH's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Rodos BioTarget GmbH in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Rodos BioTarget GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Rodos BioTarget GmbH and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Rodos BioTarget GmbH
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Rodos BioTarget GmbH and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Rodos BioTarget GmbH Snapshot
    • Rodos BioTarget GmbH Overview
    • Key Information
    • Key Facts
  • Rodos BioTarget GmbH - Research and Development Overview
    • Key Therapeutic Areas
  • Rodos BioTarget GmbH - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Rodos BioTarget GmbH - Pipeline Products Glance
    • Rodos BioTarget GmbH - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Rodos BioTarget GmbH - Drug Profiles
    • RBT-05
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RBT-06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RBT-07
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RBT-08
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Rodos BioTarget GmbH - Pipeline Analysis
  • Rodos BioTarget GmbH - Pipeline Products by Molecule Type
  • Rodos BioTarget GmbH - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Rodos BioTarget GmbH, Key Information
  • Rodos BioTarget GmbH, Key Facts
  • Rodos BioTarget GmbH - Pipeline by Indication, 2015
  • Rodos BioTarget GmbH - Pipeline by Stage of Development, 2015
  • Rodos BioTarget GmbH - Monotherapy Products in Pipeline, 2015
  • Rodos BioTarget GmbH - Preclinical, 2015
  • Rodos BioTarget GmbH - Discovery, 2015
  • Rodos BioTarget GmbH - Pipeline by Molecule Type, 2015

List of Figures

  • Rodos BioTarget GmbH - Pipeline by Top 10 Indication, 2015
  • Rodos BioTarget GmbH - Pipeline by Stage of Development, 2015
  • Rodos BioTarget GmbH - Monotherapy Products in Pipeline, 2015
  • Rodos BioTarget GmbH - Pipeline by Top 10 Molecule Type, 2015
Back to Top